42
Views
25
CrossRef citations to date
0
Altmetric
Research Article

Estimates of neutron relative biological effectiveness derived from the Japanese atomic bomb survivors

Pages 715-726 | Published online: 03 Jul 2009

References

  • BRENNER, D. J., 1991, Significance of neutrons from the atomic bomb at Hiroshima for revised radiation risk estimates. Health Physics, 60, 439–442.
  • BRENNER, D. J., 1996, Direct biological evidence for a significant neutron dose to survivors of the Hiroshima atomic bomb. Radiation Research, 145, 501–507.
  • BRENNER, D. J. and SACHS, R. K, 1994, Chromosomal `finger-prints' of prior exposure to densely ionizing radiation. Radiation Research, 140, 134–142.
  • BRENNER, D. J. and SACHS, R. K.71996, Comments on `Comment on the ratio of chromosome-type dicentric interchanges to centric rings for track-clustered compared with random breaks' by Savage and Papworth (Id adiat. Res. 146, 236-2407 1996) (letter). Radiation Research, 146, 241–242.
  • DOBSON, R. L., STRAUME, T., CARRANO, A. V., MINKLER, J. L., DEAVEN, L. L., LITTLEFIELD, L. G. and AW AA. A" 1991, Biological effectiveness of neutrons from Hiroshima bomb replica: results of a collaborative cytogenetic study. Radiation Research, 128, 143–149.
  • GRIMWOOD, P. and CHARLES, M. W., 1994, The possible reper-cussions of further revisions in the Japanese atomic bomb dosimetry. In Proceedings of the I 7 th IRPA Regional Congress, edited by W. Nimmo-Scott and D. J. Golding (Ashford: Nuclear Technology Publishing), pp. 213–216.
  • Internation Commission on Radiological Protection (ICRP), 1991, 1990 Recommendations of the International Commission on Radiological Protection. Annals of the IC RP, 21(1–3) (Oxford: Pergamon).
  • International Commission on Radiation Units and Measurements (ICRU), 1986, The Quality Factor in Radiation Protection. ICRU Report 40 (Bethesda, MD: ICRU).
  • LEENHOUTS, H. P. and CHADWIC KK. F1.7 1994, A two-mutation model of radiation carcinogenesis: application to lung tumours in rodents and implications for risk evaluation. Journal of Radiological Protection, 14, 115–130.
  • LITTLE, M. P. and CHARLES, M. W., 1997, The risk of non-melanoma skin cancer incidence in the Japanese atomic bomb survivors. International Journal of Radiation Biology, 71, 589–602.
  • LITTLE, M. P. and MUIRHEAD, C. R., 1996, Evidence for curvilinearity in the cancer incidence dose-response in the Japanese atomic bomb survivors. International Journal of Radiation Biology, 70, 83–94.
  • LITTLE, M. P., DE VATHAIRE, F., CHARLES, M. W., HAWKINS, M. M. and MUIRHEAD, C. R., 1997a, Variations with time and age in the relative risks of solid cancer incidence after radiation exposure. Journal of Radiological Protection, 17, 159–177.
  • LITTLE, M. P., MUIRHEAD, C. R. and CHARLES, M. W., 1997b, Describing time and age variations in the risk of radiation-induced solid tumour incidence in the Japanese atomic bomb survivors using generalised relative and absolute risk models. Submitted to Statistics in Medicine.
  • MCCULLAGH, P. and NELDER, J. A" 1989, Generalized Linear Models, 2nd edn (London: Chapman & Hall).
  • MILTON, R. C. and SHOHOJI, T., 1968, Tentative 1965 Radiation Dose Estimates for Atomic Bomb Survivors, Hiroshima and Nagasaki. ABCC Technical Report TR 1–68 (Hiroshima: Atomic Bomb Casualty Commission).
  • NAGATOMO, T., HOSHI, M. and ICHIKAWA, )(.7 1995, Thermoluminescence dosimetry of the Hiroshima atomic-bomb gamma rays between 1.59 km and 1.63 km from the hypocenter. Health Physics, 69, 556–559.
  • National Council on Radiation Protection and Measurements (NCRP), 1990, The Relative Biological Effectiveness of Radiations of Different Quality. NCRP Report 104 (Bethesda, MD: NCRP).
  • PRESTON, D. L. and PIERCE, D. A., 1987, The Effect of Changes in Dosimetry on Cancer Mortality Risk Estimates in the Atomic Bomb Survivors. RERF Technical Report TR 9–87 (Hiroshima: Radiation Effects Research Foundation).
  • PRESTON, D. L. and SPOSTO, R., 19917 RBE and Dose-Response Functions. RERF Update, 3 (3) (Hiroshima: Radiation Effects Research Foundation), pp. 3–4.
  • PRESTON, D. L., KusumL S., TOMONAGA, M., IZUMI, S., RON, E., KURAMOTO, A., KAMADA, N., DOHY, H., MATSUO, T., NONAKA, H., THOMPSON, D. E., SODA, M. and MABUCHI, K., 1994, Cancer incidence in atomic bomb survivors. Part III: leukemia, lymphoma and multiple myeloma, 1950–1987. Radiation Research, 137, S68—S97.
  • PRESTON, D. L., MABUCHI, K., PIERCE, D. A. and SHIMIZU, )(.7 1997, Mortality among atomic-bomb survivors, 1950-1990. In Proceedings of the Thirty- Second Annual Meeting of the National Council on Radiation Protection and Measurements. Proceedings No. 18. Implications of New Data on Radiation Cancer Risk, edited by J.D. Boice (Bethesda, MD: NCRP), pp. 31–39.
  • PIERCE, D. A., SHIMIZU, Y., PRESTON, D. L., VAETH, M. and MABUCHI, K., 1996, Studies of the mortality of atomic bomb survivors. Report 12, part I. Cancer: 1950–1990. Radiation Research, 146, 1–27.
  • ROESCH, W. C. (ed.), 1987a, US-Japan Joint Reassessment of Atomic Bomb Radiation D osimetry in Hiroshima and Nagasaki. Volume I (Hiroshima: Radiation Effects Research Foundation). ROESCH, W. C. (ed.), 1987b, vs-Japan Joint Reassessment of Atomic Bomb Radiation D osimetry in Hiroshima and Nagasaki. Volume 2 (Hiroshima: Radiation Effects Research Foundation).
  • Rossi, H.H. and MAYS, C.W., 1978, Leukemia risk from neutrons. Health Physics, 34, 353–360.
  • Rossi, H. H. and ZAIDER, M., 1990, Contributions of neutrons to the biological effects in Hiroshima. Health Physics, 58, 645–647.
  • Rossi, H. H. and ZAIDER, M., 1991, Neutron RBE for A-bomb Survivors. RERF Update, 3 (1) (Hiroshima: Radiation Effects Research Foundation), pp. 3–4.
  • SAVAGE, J. R. K. and PAPWORTH, D. G., 1996, Comment on the ratio of chromosome-type dicentric interchanges to centric rings for track-clustered compared with random breaks. Radiation Research, 146, 236–240.
  • SHIMIZU, Y., KATO, H. and ScHuLL, W. J., 1990, Studies of the mortality of A-bomb survivors. 9. Mortality, 1950–1985: Part 2. Cancer mortality based on the recently revised doses (D586). Radiation Research, 121, 120–141.
  • SHIZUMA, K., IWATANI, K., HASAI, H., HOSHI, M., OKA, T. and MORISHIMA, H., 1993, Residual 152Eu and mCo activities induced by neutrons from the Hiroshima atomic bomb. Health Physics, 65, 272–282.
  • STRAM, D. 0., SPOSTO, R., PRESTON, D., ABRAHAMSON, S., HONDA, T. and AWA, A. A., 1993, Stable chromosome aberrations among A-bomb survivors: an update. Radiation Research, 136, 29–36.
  • STRAUME, T., 1995, High-energy gamma rays in Hiroshima and Nagasaki: implications for risk and wR. Health Physics, 69, 954–956.
  • STRAUME, T., 1996, Risk implications of the neutron discrepancy in the Hiroshima D586 dosimetry system. Radiation Protection D osimetry, 67, 9–12.
  • STRAUME, T., EGBERT, S. D., WOOLSON, W. A., FINKEL, R. C., KUBIK, P. W., GOVE, H. E., SHARMA, P. and HOSHI, M.7 1992, Neutron discrepancies in the D586 Hiroshima dosimetry system. Health Physics, 63, 421–426.
  • STRAUME, T., HARRIS, L. J., MARCHETTI, A. A. and EGBERT, S. D., 1994, Neutrons confirmed in Nagasaki and at the Army Pulsed Radiation Facility: implications for Hiroshima. Radiation Research, 138, 193–200.
  • STRAUME, T., MARCHETTI, A. A. and MCANINCH, J. E.7 1996, New analytical capability may provide solution to the neutron dosimetry problem in Hiroshima. Radiation Protection D osimetry, 67, 5–8.
  • THOMPSON, D. E., MABUCHI, K., RON, E., SODA, M., TOKUNAGA, M., OCHIKUBO, S., SUGIMOTO, S., IKEDA, T., TERASAKI, M., IZUMI, S. and PRESTON, D. L., 1994, Cancer incidence in atomic bomb survivors. Part II: solid tumors, 1958-1987. Radiation Research, 137, S17—S67.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.